Latest News and Press Releases

SALT LAKE CITY, July 13, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, today announced it has received U. S. Food and Drug Administration (FDA)...

New Business Pipeline exceeds $5.0 million in potential new revenue; Nearly $2.0 million in potential pipeline revenue is from Stool Bacterial Pathogens Panel, currently awaiting FDA clearance SALT...

SALT LAKE CITY, June 22, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, today announced it has closed a previously-announced registered offering...

SALT LAKE CITY, June 20, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN) (the “Company” or “Great Basin”), a molecular diagnostics company, today announced it has priced a...

SALT LAKE CITY, June 01, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, announced today that it will present three posters describing the...

SALT LAKE CITY, May 24, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, today announced that the United States Patent and Trademark Office...

Company continues to reduce operating expenses and cash burn First quarter revenue increased 14% year-over-year30% reduction in first quarter total operating expenses compared to fourth quarterFirst...

SALT LAKE CITY, May 16, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, today announced the U.S. commercial launch of its Bordetella Direct Test...

SALT LAKE CITY, May 15, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, today announced that holders of the 2017 Series B Senior Secured...

SALT LAKE CITY, May 05, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, announced today that its shares of common stock will be quoted under the...